期刊文献+

川崎病患儿血清中性粒细胞激活肽-78和内脂素水平变化及其意义研究 被引量:5

Clinical Significance of ENA-78 and Visfatin and Their Association with Kawasaki Disease
下载PDF
导出
摘要 目的探讨川崎病患儿血清中性粒细胞激活肽-78(ENA-78)和内脂素水平的变化及临床意义。方法采用酶联免疫法检测90例川崎病患儿和30例健康体检儿童的血清ENA-78和内脂素水平。结果川崎病组患儿血清中ENA-78水平〔(163±22)ng/L〕明显高于对照组〔(64±12)ng/L〕,内脂素水平〔(32±5)μg/L〕也明显高于对照组〔(17±4)μg/L〕,差异均有统计学意义(P<0.05)。川崎病组中冠状动脉损伤患儿血清ENA-78水平〔(217±30)ng/L〕明显高于冠状动脉正常患儿〔(129±20)ng/L〕,内脂素水平〔(37±5)μg/L〕也明显高于冠状动脉正常患儿〔(28±5)μg/L〕,差异均有统计学意义(P<0.05)。川崎病组患儿血清ENA-78水平与内脂素水平呈正相关(r=0.67,P<0.05)。结论 ENA-78和内脂素水平在川崎病尤其伴冠状动脉损伤时明显升高,可作为判断川崎病冠状动脉损伤的参考指标。 Objective To explore the levels and clinical significance of epithelial neutrophil - aetiving peptide - 78 ( ENA - 78 ), visfatin in the serum of children with Kawasaki diseases (KD) . Methods Serum level of ENA - 78 and visfatin was measured in 90 children with KD and 30 healthy children by ELISA, and the outcome was estimated in combination with clinical symptoms. Results The serum levels of ENA - 78 and visfatin in children with KD were significantly higher compared with that of the control group ( P 〈 0. 05 ) ; The serum levels of ENA - 78 and visfatin in children of KD with coronary artery lesion (CAL) were significantly higher compared with that of children of KD without CAL ( P 〈 0. 05 ). In children with KD, the serum levels of ENA - 78 and visfatin had a positive correlation ( r = 0. 67, P 〈 0.05 ). Conclusion Serum levels of ENA - 78 and visfatin are increased in the acute phase of KD, and are significantly higher in those KD children with CAL. ENA - 78 and visfatin may be used as an important serological indicator of KD with CAL.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第3期283-284,共2页 Chinese General Practice
关键词 川崎病 黏膜皮肤淋巴结综合征 冠状动脉狭窄 冠状动脉瘤 Kawasaki disease Mucocutaneous lymph node syndrome Coronary stenosis Coronary aneurysm
  • 相关文献

参考文献11

  • 1Mc Crindle BW, Li JS, Minich LL, et al. Coronary artery in volvemen- tin children with kawasaki disease: risk factors from analysis of serial normalized 179. ts [J]. Circulation, 2007, 116 (2): 174-.
  • 2Liu GN, Shi HZ, Xie ZH, et al. Epithelial neutrophil - activating peptide- 78 recruits neutrophils into pleural effusion [ J]. Eur Respir J, 2009, 34 (1): 184-190.
  • 3Zhong M, Tan HW, Gong HP , et al. Increased serum visfatin in pa- tients with metabolic syndrome and carotid a the roscle rusis [ J ]. Clin Endocrinol, 2008, 69 (6): 878-884.
  • 4无,赵晓东(整理),杜忠东(整理).川崎病专题讨论会纪要[J].中华儿科杂志,2007,45(11):826-830. 被引量:149
  • 5胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 6Frick VO, Rubie C, Wagner M, et al. Enhanced ENA - 78 and IL - 8 expression in patients with malignant pancreatic diseases [ J ]. Pancre- atology, 2008, 8 (4/5): 488-497.
  • 7Bersinger NA, Frischknecht F, Taylor RN, et al. Basal and cytokine -stimulated production of epithelial neutrophil activating peptide -78 ( ENA - 78 ) and interleukin - 8 ( IL - 8 ) by cultured human endometfi- al epithelial and stromal cells [ J ]. Fertil Steril, 2008, 89 ( 5 Sup- pl) : 1530 - 1536.
  • 8Lim SY, Davidson SM, Paramanathan A J, et al. The novel adipocyto- kine visfatin exerts direct cardioprotective effects [ J]. J Mol Med, 2008, 12 (4): 1395-1403.
  • 9Adya R, Tan BK, Punn A, et al. Visfatin induces human endothelial VEGF and MMP - 2/9 production via MAPK and PI3K/Akt signaling pathways: novel insights into visfatin induced angiogenesis [J]. Cadiu- vascRes, 2008, 78 (2): 356-365.
  • 10Kim SR, Bae YH, Bae SK, et al. Visfatin enhances ICAM -1 and VCAM - 1 expression through ROS dependent NF - kappa B activation in endothelial cells [J]. Biochim Biophys Acta, 2008, 1783 (5) : 886 - 895.

二级参考文献23

  • 1金虹 梁翊常 等.正常儿童冠状动脉超声心动图研究[J].中华儿科杂志,1988,26:257-259.
  • 2Mason J, Siriwardena AK. Designing future clinical trials in acute pancreatitis. Pancreatology, 2005, 5 : 113-115.
  • 3Muse ED, Obici S, Bhanot S, et al. Role of resistin in dietinduced hepatic insulin resistance. J Clin Invest, 2004, 114: 232-239.
  • 4Lehrke M, Reilly MP, Millington SC, et al. An inflammatory cascade leading to hyperresistinemia in humans. Plos Med, 2004,1:45-55.
  • 5Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation, 1993, 87: 1776- 1780.
  • 6Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Bheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 2004, 110 : 2747-2771.
  • 7Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int, 2005, 47:232-234.
  • 8Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics, 2004. 114: 1708-1733.
  • 9Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo : Ministry of Health and Welfare, 1984.
  • 10de Zorzi A, Colan SD, Gauvreau K, et aL Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr, 1998,133:254-258.

共引文献2061

同被引文献32

  • 1Yao-BorengasserA, Varma V, Bodles AM, et al. Retinol binding protein 4 expression in humans:relationship to insulin resistance, inflamma- tion, and response to pioglitazone[ J]. J Clin Endocrinol Metab ,2007, 92 ( 7 ) : 2590-2597.
  • 2Seo JA, Kim NH, Park SY, et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease [ J ]. Clin Endocrinol (Oxf) ,2008,68 (4) :555-560.
  • 3Perseghin G, Lattuada G, De C, et al. Serum retinol-binding prqtein-4, leptin, and adiponectln concentrations are related to eetopic fat accu- mulation[ J]. J Clin Endocrinol Metab,2007 ,92(12) :4883-4888.
  • 4Alfadda AA, Alzoghaibi MA. Circulatory neutrophil chemokines in sta- tin-treated diabetic patients[ J]. Saudi Med J,2008,29(4) :584-588.
  • 5Vasakova M, Sterclova M, Kolesar L, et al. Cytokine gene polymor- phisms and BALF cytokine levels in interstitial lung diseases[ J]. Re- spir Med,2009,103 (5) :773-779.
  • 6Liu GN, Shi HZ, Xie ZH, et al. Epithelial neutrophil-activating pep- tide-78 recruits neutrophils into pleural effusion [J]. Eur Respir J, 2009,34( 1 ) : 184-190.
  • 7Frick VO, Rubie C,Wagner M, et al. Enhanced ENA-78 and IL-8 ex- pression in patients with malignant pancreatic diseases[ J ]. Pancreatol- ogy,2008,8(4-5 ) :488-497.
  • 8Gerber M A,Baltimore R S,Eaton C B,et al.Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis A Scientific Statement From the American Heart Association Rheumatic Fever,Endocarditis,and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young,the Interdisciplinary Council on Functional Genomics and Translational Biology,and the Interdisciplinary Council on Quality of Care and Outcomes Research:Endorsed by the American Academy of Pediatrics[J].Circulation,2009,119(11):1541-1551.
  • 9Manlhiot C,Niedra E,McCrindle B W.Long-term management of Kawasaki disease:implications for the adult patient[J].Pediatrics & Neonatology,2013,54(1):12-21.
  • 10Yeung R S M.Kawasaki disease:update on pathogenesis [J].Current Opinion in Rheumatology,2010,22(5):551-560.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部